Health Technology Assessment- Drivers of Additional Benefit Scoring and the Impact on Orphan Drug Pricing in France
Sep 1, 2018, 00:00 AM
10.1016/j.jval.2018.07.851
https://www.valueinhealthjournal.com/article/S1098-3015(18)33208-X/fulltext
Section Title :
Section Order :
84
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33208-X&doi=10.1016/j.jval.2018.07.851